DOI:

How does inflammation influence left ventricular function after TAVI?

Vavuranakis M., Kariori M., Aznaouridis K., Moldovan C., Vrachatis D., Kalogeras K., Stefanadis C.

Pot-pourri

How does inflammation influence left ventricular function after TAVI?

Aims: Transcatheter aortic valve implantation (TAVI) is an emerging treatment option for inoperable or high-risk patients. After the procedure, most patients show significant improvement of left ventricular function. However, the recovery of the left ventricle is not immediately observed in all patients, while in some there is a temporary deterioration. Furthermore, elevated levels of CRP and white blood cells (WBC) are observed in some patients after TAVI. Elevated CRP has been associated with reduced left ventricular function. Therefore, we hypothesised that inflammatory parameters may influence left ventricular recovery after TAVI.

Methods and results: Data from 76 consecutive patients (80.37±5.36 years, 33 males (48.8%), AVA: 0.63±0.15 cm2) who underwent TAVI were evaluated from an existing database. Blood samples were obtained before TAVI, three hours and daily for five days after the procedure. CRP as well as WBC were recorded. In addition, transthoracic echocardiogram was performed and obtained before TAVI and daily for five days after the procedure. Patients were separated into three groups according to left ventricle improvement (improved, declined, unaffected). From these groups, LVEF improved in 29 patients (39.7%), declined in 11 patients (15.1%) and remained unaffected in 33 patients (45.2%). We performed the ANOVA statistical test among the three groups and found significant differences between them for CRPmax (p<0.01) and WBC1st day after (p<0.01). In particular, post hoc analysis showed higher levels of CRPmax (70.2±49.28 vs. 120±22.36, p<0.01) and WBC1st day after (16,333±4,685 vs. 11,748±3,512, p<0.01) in patients with declined LVEF compared to those with unaffected LVEF, respectively. Similarly, post hoc analysis recorded greater value for CRPmax (120±22.36 vs. 61.99±36.9, p<0.01) and WBC1st day after (16,528±4,890 vs. 10,800±2,687, p<0.01) in patients with declined LVEF when compared with those with improved LVEF.

Conclusions: In conclusion, inflammation as detected by simple indices such as WBC and CRP may be associated with left ventricular function after TAVI.

Volume 8 Supplement Q
Sep 30, 2012
Volume 8 Supplement Q
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00068 Mar 4, 2024
Acute changes in microvascular resistance after treating aortic stenosis
Johnson N and Eerdekens R
free

Clinical research

10.4244/EIJ-D-22-00817 Jun 19, 2023
Impact of early changes in cardiac damage following transcatheter aortic valve implantation
Zhou Y et al
free

CLINICAL RESEARCH

10.4244/EIJY15M02_02 Apr 20, 2016
The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation
Sinning J et al
free
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
154.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
47.4

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
43.65

Clinical research

10.4244/EIJ-D-23-00590 Dec 4, 2023
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Nakase M et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
34.75

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved